Orizuru Therapeutics Inc. announced that it has received funding from Kyoto University Innovation Capital Co., Ltd., SMBC Venture Capital Co., Ltd., MediPal Holdings Corporation
August 09, 2021
Share
Orizuru Therapeutics Inc. announced that it has received a round of funding on August 10, 2021. The transaction included participation from MediPal Holdings Corporation and new investors Kyoto University Innovation Capital Co., Ltd. and SMBC Venture Capital Co., Ltd.
MEDIPAL HOLDINGS CORPORATION engages in the wholesale of pharmaceutical products, cosmetics and daily miscellaneous goods. The Company operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The Company is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
Orizuru Therapeutics Inc. announced that it has received funding from Kyoto University Innovation Capital Co., Ltd., SMBC Venture Capital Co., Ltd., MediPal Holdings Corporation